“Departing the agency are Office of Vaccines Research and Review Director Marion Gruber, Ph.D. and Deputy Director Phillip Krause, M.D. Gruber plans to retire on Oct. 31, while Philips – deputy director for the FDA\u2019s Center for Biologics Evaluation and Research, will be leaving in November. ”<\/p>\n
“”A former senior FDA leader told Endpoints that they\u2019re departing because\u00a0they\u2019re frustrated that CDC and their ACIP committee are involved in decisions that they think should be up to the FDA<\/em>. The former FDAer also said he\u2019s heard they\u2019re upset with CBER director Peter Marks for not insisting that those decisions should be kept inside FDA. What finally did it for them was the White House getting ahead of FDA on booster shots.”<\/strong><\/p>\n https:\/\/www.zerohedge.com\/covid-19\/two-senior-fda-officials-stepping-down-over-reported-disagreements-white-house-over<\/a><\/p>\n","protected":false},"excerpt":{"rendered":" “Departing the agency are Office of Vaccines Research and Review Director Marion Gruber, Ph.D. and Deputy Director Phillip Krause, M.D. Gruber plans to retire on Oct. 31, while Philips – deputy director for the FDA\u2019s Center for Biologics Evaluation and … Continue reading